KN

Krishnan Nandabalan

President, Chairman, and CEO of AlphaMeld Corporation

InveniAI GmbH

Branford, Connecticut


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
InveniAI GmbH
Industry
information technology & services
Employees
25.0
Seniority
C suite
Annual Revenue
2400000.0

Technologies

Route 53 Outlook Amazon AWS Amazon SES Google Font API WordPress.org Mobile Friendly

Keywords

artificial intelligence big data analytics deep machine learning drug discovery innovation monitoring innovation scanning predictive analytics ai-driven drug discovery machine learning generative ai target identification drug design therapeutics development biopharma collaboration clinical trial strategy biomarker discovery data analysis healthcare innovation evidence-based drug development clinical success probability obesity research disease-target-drug association drug efficacy therapeutic modalities precision medicine adaptive study design highlighting gene pathways biomolecular interactions patient solutions ai-based insights innovative therapies pipeline development data-driven drug discovery accelerated r&d functional insights regulatory success clinical landscape mapping disease modeling data integration translational research biological insights ai platform drug discovery lifecycle therapeutic advancements clinical trial support ai-powered assistant chatalphameld target prioritization cutting-edge technology pharmaceutical applications ai collaboration translational drug discovery therapeutic innovation information technology & services enterprise software enterprises computer software b2b data analytics

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans